Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2026-02-27 @ 11:10 AM
Study NCT ID:
NCT05871918
Status:
UNKNOWN
Last Update Posted:
2023-05-23
First Post:
2023-05-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Multicenter, Randomized, Open, Phase III Trial of ddEC-THPvs Evaluating the Efficacy and Safety of TCHP Neoadjuvant Therapy for HER2-positive Breast Cancer
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HER-2 Positive Breast Cancer | View |
Keywords: